Article Topic
July 22, 2024: A Michigan pharmacy sues supplier over fake Ozempic
A Michigan company is suing a telepharmacy that allegedly supplied fake Ozempic. New resources about the risks of compounded medicines. Details about the fake cancer drug ring busted in India.
[...]Patients face safety risks with counterfeit and compounded prescription weight-loss drugs
Patients face safety risks with counterfeit and compounded prescription weight-loss drugs Officials warn of counterfeit and compounding pharmacy concerns as demand for weight-loss medicines surges. Demand is skyrocketing for FDA-approved medicines that provide incredible benefits to patients living with diabetes and obesity. The injectables – GLP-1s like semaglutide and incretins that are commonly known as…
[...]July 15, 2024: What some fake Botox victims have endured
New information on the patients recently hurt by counterfeit Botox, two news stories involving pill presses, and a prosecution announced in Austria over fake Ozempic that sent multiple people to the hospital.
[...]Have patients been harmed by unsafe drug compounding?
Have patients been harmed by unsafe drug compounding? Compounded medicine is an important part of our healthcare system. It’s meant to be an exception to the normal drug supply chain, helping patients who cannot take a drug in its existing form or filling in when there are shortages of a life-saving medication. However, compounding pharmacies…
[...]Problems inspectors found in compounding facilities
Problems inspectors found in compounding facilities There are two types of compounding pharmacies that help patients. 503A pharmacies provide bespoke medications to suit patients’ requirements if mass-produced medicine can’t meet them. 503B pharmacies, known as outsourcing facilities, can create large batches of medication specifically for healthcare facilities to use in-office. There are approximately 7,500 compounding…
[...]Lawsuits filed against businesses selling compounded injectables for diabetes and weight-loss
Lawsuits filed against businesses selling compounded injectables for diabetes and weight-loss Novo Nordisk and Eli Lilly, who developed and won FDA approval for their blockbuster weight-loss and diabetes medicines, Ozempic, Wegovy, Mounjaro and Zepbound, have been suing businesses who they say are marketing compounded versions of these drugs with false claims. These medical spas, wellness…
[...]July 8, 2024: U.S. legislators introduce a bill to curb fake pill sales on social media
The Cooper Davis and Devin Norring Act would force social media to report online drug sales. Additional news involves counterfeit cancer drugs sold in the U.S., fake cosmetic injections and more.
[...]July 1, 2024: Safe Chain Solutions owners indicted for selling black market HIV drugs
Adam Brosius, Patrick Boyd and Charles Boyd are facing eight counts for selling $90 million of diverted prescription drugs from five black-market suppliers.
[...]PSM applauds the reintroduction of the SHOP SAFE Act
On June 13, 2024, PSM sent a letter to Congressmen Darrell Issa and Jerrold Nadler applauding the reintroduction of the Stopping Harmful Offers on Platforms by Screening Against Fake E-Commerce (SHOP SAFE) Act.
[...]June 25, 2024: WHO alert about counterfeit Ozempic; a warning about fake Mounjaro and Zepbound
Fake Ozempic has been found in Brazil, the U.K., and the U.S. Eli Lilly warned the public about fake and compounded tirzepatide medicines. Additional domestic and international stories.
[...]